HomeAI · summaries
Storia in 3 fonti
In 2020, Alzheimer’s diagnose process received major breakthrough approval, six years later 7 million patient in U.S. get another big announcement for progressive brain disease treatment
More than 7 million people in the United States have Alzheimer's, and the number of people aged 65 or older with the disease could exceed 13 million by 2050.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA approves Tauklarify for PET imaging of tau neurofibrillary tangle pathology
The FDA has approved Tauklarify as a radiodiagnostic agent for adults with cognitive impairment being evaluated via PET scan to identify tau neurofibrillary tangle pathology…
- ·
benzinga.com
FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics - Lantheus Holdings (NASDAQ:LNTH)
Lantheus receives FDA approval for PET imaging agent used to evaluate adults for Alzheimer's disease by identifying tau pathology.
